Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» nonalcoholic steatohepatitis
nonalcoholic steatohepatitis
After hep C cure, companies target next big liver disease market
Yahoo/Reuters
Sun, 11/9/14 - 09:46 am
hepatitis B
hepatitis
nonalcoholic steatohepatitis
Gilead
Galmed Pharmaceuticals
Raptor Pharmaceuticals
Conatus Pharmaceuticals
Intercept Pharma Shares Higher on Positive Fatty Liver Drug Data
TheStreet.com
Mon, 08/11/14 - 06:11 pm
Intercept Pharma
OCA
nonalcoholic steatohepatitis
The next hepatitis C? NASH
CNBC
Tue, 07/15/14 - 09:48 am
NASH
hepatitis C
liver disease
nonalcoholic steatohepatitis
Genfit
Gilead Sciences
Intercept Pharma
Intercept CEO says new drug could treat ‘next tsunami’ in liver disease
Marketwatch
Wed, 01/15/14 - 05:21 pm
Intercept Pharma
liver disease
nonalcoholic steatohepatitis
OCA
Intercept Liver Drug Is A Game Changer For The Biotech Industry
Seeking Alpha
Sun, 01/12/14 - 09:47 am
nonalcoholic steatohepatitis
Intercept Pharma
obeticholic acid
Isis Adds Three New Drugs to Its Development Pipeline
Yahoo
Thu, 12/15/11 - 09:45 am
Isis Pharmaceuticals
ISIS-FVIIRx
ISIS-DGAT2Rx
ISIS-APOARx
nonalcoholic steatohepatitis
thrombotic diseases
atherosclerosis